Master Thesis (f/m/d) | In-vitro glycoengineering of vaccine candidates against filovirus infections in humans produced in insect cells
The in-vitro glycoengineering (IVGE) platform consists in the use of different recombinant glycosyltransferases together with the corresponding nucleotide sugars to generate specific glycoforms. The group of synthetic glycobiotechnology at Max Planck Institut of Complex Technical Systems Magdeburg has been working on this platform to produce specific N-glycans using different viral glycoproteins as a start material, such as … Read more










